bezafibrate has been researched along with orlistat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gagnon, C; Garcia-Ac, A; Sauvé, S; Segura, PA | 1 |
| Gagnon, C; Garcia-Ac, A; Sauvé, S; Segura, PA; Viglino, L | 1 |
3 other study(ies) available for bezafibrate and orlistat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Determination of bezafibrate, methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters using on-line solid-phase extraction liquid chromatography coupled to polarity-switching electrospray tandem mass spectrometry.
Topics: Bezafibrate; Chromatography, Liquid; Cyclophosphamide; Enalapril; Environmental Monitoring; Lactones; Methotrexate; Orlistat; Solid Phase Extraction; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical; Water Purification; Water Supply | 2009 |
Comparison of APPI, APCI and ESI for the LC-MS/MS analysis of bezafibrate, cyclophosphamide, enalapril, methotrexate and orlistat in municipal wastewater.
Topics: Bezafibrate; Chromatography, Liquid; Cyclophosphamide; Enalapril; Flow Injection Analysis; Lactones; Mass Spectrometry; Methotrexate; Orlistat; Sewage; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water; Water Pollutants, Chemical | 2011 |